Psych360’s Cognitive Preservation Rx program focuses on Dementia and Alzheimer’s diseases. The goal of this program is for early mental-health intervention as it relates specifically to these diseases. Many times the tendency is to wait or delay mental-health provider care for a variety of reasons. However, the earlier appropriate and reasonable mental-health care can be offered to the patient the more of a proactive approach can be administered rather than a reactive response to the symptoms experienced as a result of the ongoing disease process. This is critical in minimizing the symptoms associated with the disease process. The less disruptions to the routine and quality of life the patients experience the more manageable the disease process.
There are mainly two types of medication therapies for this disease:
- Cognitive enhancer medications which may slow down the disease progression.
- Symptomatic therapies are available but do not act on the evolution of the disease.
Secondary symptoms of dementia include depression, anxiety, agitation, aggression, hallucinations, delusions, paranoia, insomnia and sleep disorders. These can be problematic and the more severe these symptoms the greater the impact on the patients condition. Behavioral symptoms in particular are common and can exacerbate cognitive and functional impairment and influence a more rapid decline of the disease.
The following psychotropic medications have been used to treat these secondary symptoms. Psychotropic meds can include anti-depressants, anti-psychotics and anti-anxiety medications, as well as mood-stabilizers and hypnotic medications. These drugs may be prescribed at times to treat some of the behavioral and emotional symptoms of Alzheimer’s disease. This class of medications is typically used after attempting non-pharmacologic interventions consistently and finding them to be ineffective.
While these medications can be productive at times, minimizing the addition of medications is important in reducing polypharmacy. If successful, this can result in improved cognition and quality of life.
It is the goal of this program to implement a coordinated effort to preserve the mental-health and cognitive function of the patients to enhance quality of life for as long as possible during this disease process.